Correlation Between Pmv Pharmaceuticals and RAPT Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and RAPT Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and RAPT Therapeutics.

Diversification Opportunities for Pmv Pharmaceuticals and RAPT Therapeutics

-0.01

Correlation Coefficient

Pmv Pharmaceuticals  RAPT Therapeutics

Good diversification

The 3 months correlation between Pmv and RAPT is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and RAPT Therapeutics go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and RAPT Therapeutics

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.38 times more return on investment than RAPT Therapeutics. However, Pmv Pharmaceuticals is 2.63 times less risky than RAPT Therapeutics. It trades about -0.01 of its potential returns per unit of risk. RAPT Therapeutics is currently generating about -0.22 per unit of risk. If you would invest  160.00  in Pmv Pharmaceuticals on September 15, 2024 and sell it today you would lose (2.00) from holding Pmv Pharmaceuticals or give up 1.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  RAPT Therapeutics

Pmv Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Pmv Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

RAPT Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RAPT Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Pmv Pharmaceuticals and RAPT Therapeutics

The main advantage of trading using opposite Pmv Pharmaceuticals and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.

The idea behind Pmv Pharmaceuticals and RAPT Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.